Acadia Pharmaceuticals buy Needham & Company LLC
Start price
12.03.24
/
50%
€18.20
Target price
12.03.25
€29.32
Performance (%)
-14.20%
Price
26.04.24
€15.62
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.20%. This prediction currently runs until 12.03.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | - | - |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Needham & Company LLC from $36.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.56
09.04.24
09.04.24
€29.40
09.04.25
09.04.25
-2.60%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-27.71%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.80
24.01.24
24.01.24
€33.86
24.01.25
24.01.25
-34.98%
26.04.24
26.04.24